香港股市 將收市,收市時間:3 小時 53 分鐘

Agilent Technologies, Inc. (AG8.F)

Frankfurt - Frankfurt 延遲價格。貨幣為 EUR。
加入追蹤清單
134.60+6.22 (+4.84%)
收市:08:20AM CEST

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
https://www.agilent.com

版塊Healthcare
行業Diagnostics & Research
全職員工17,700

高階主管

名稱頭銜支付行使價出生年份
Mr. Padraig McDonnellCEO, COO, President & Director982.46k
Mr. Robert W. McMahonSenior VP, CFO and Interim President of Diagnostics & Genomics Group997.01k1969
Mr. Henrik Ancher-JensenSenior VP and President of Order Fulfillment & Supply Chain859.86k1965
Mr. Rodney GonsalvesPrincipal Accounting Officer, VP & Corporate Controller1966
Mr. John KohlSenior Vice President & Chief Information Officer
Ms. P. Diana ChiuVP, Interim General Counsel & Secretary
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global Communications868.08k1959
Ms. Allison BallmerSenior Vice President of Strategy & Corporate Development
Ms. Yvonne MackieMD of UK & Ireland Operations and VP of Human Resources - Europe
Ms. Jenipher E. DaltonSenior VP, Chief Quality & Regulatory Officer
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

公司管治

截至 2024年5月1日 止,Agilent Technologies, Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中:8;董事會:4;股東權利:9;現金賠償:4。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。